Fundraising FoxNorthstar Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Jerzy Kozyra(CEO)inMun Ching Lee(Cofounder)in
Co-investorsEarlymarketEntrepreneur First
NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform.
BiotechDeep TechHardwareNew MaterialsNewcastle upon Tyne, GB
Co-investorsAscensionEMV CapitalMartlet CapitalMaven Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.